Angela Russo, Zizhao Yang, Georgette Moyle Heyrman, et al. Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer. Cancer Letters. 2022;543:215779. doi:10.1016/j.canlet.2022.215779
Gui-Wei He, Lin Lin, Jeff DeMartino, et al. Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation. Cell Stem Cell. 2022;29(9):1333-1345.e6. doi:10.1016/j.stem.2022.08.002
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
Claudia Günther, Beate Winner, Markus F. Neurath, Thaddeus S. Stappenbeck. Organoids in gastrointestinal diseases: from experimental models to clinical translation. Gut. 2022;71(9):1892-1908. doi:10.1136/gutjnl-2021-326560
Paul Whaley, Thomas Piggott, Rebecca L. Morgan, et al. Biological plausibility in environmental health systematic reviews: a GRADE concept paper. Journal of Clinical Epidemiology. 2022;146:32-46. doi:10.1016/j.jclinepi.2022.02.011
Sunghee Estelle Park, Shawn Kang, Jungwook Paek, et al. Geometric engineering of organoid culture for enhanced organogenesis in a dish. Nature Methods. 2022;19(11):1449-1460. doi:10.1038/s41592-022-01643-8
Dan Shu, Meiying Shen, Kang Li, et al. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. Annals of Medicine. 2022;54(1):2581-2597. doi:10.1080/07853890.2022.2122550
Sebastian Hoffmann, Paul Whaley, Katya Tsaioun. How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessment. ALTEX. 2022;39(2):175-182. doi:10.14573/altex.2201131